Last update Aug. 20, 2022
Compatible
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Sugammadex Sodium in other languages or writings:
Sugammadex Sodium belongs to this group or family:
Main tradenames from several countries containing Sugammadex Sodium in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | ≈ 0 | % |
Molecular weight | 2.178 | daltons |
Protein Binding | 0 | % |
VD | 0.2 | l/Kg |
pKa | 2.82 | - |
T½ | 2 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
It is a modified gamma-cyclodextrin that binds to rocuronium or vecuronium, reversing its neuromuscular blocking action. Used intravenously.
Since the last update we have not found published data on its excretion in breast milk.
Its high molecular weight makes it unlikely that it will pass into milk in significant amounts.
Its low oral bioavailability would make it difficult its passage to the infant’s plasma through breast milk. (EMA 2017)
Side effects are rare and mild. It is administered in single or isolated doses.
Sugammadex can be used during breastfeeding. (LactMed, EMA 2017)